Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients

Lan Zhou, John McConville, Vinay Chaudhry, Robert N. Adams, Richard L. Skolasky, Angela Vincent, Daniel B. Drachman

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

We assayed cryopreserved sera from 38 acetylcholine receptor (AChR) antibody-negative patients with myasthenia gravis (MG) who were followed clinically for muscle-specific tyrosine kinase (MuSK) antibodies and analyzed and compared their clinical characteristics. None of 13 sera from patients with purely ocular MG were positive. Sera from 10 of 25 patients (40%) with generalized MG were positive for MuSK antibodies. The age at onset of myasthenic symptoms was significantly earlier in MuSK antibody-positive patients (P = 0.02). MuSK antibodies were present in AChR antibody-negative patients of either gender, with virtually identical prevalence in women (41.2%) and men (37.5%). The distribution of weakness more commonly involved neck muscles in MuSK antibody-positive patients, and limb muscles in MuSK antibody-negative patients. Patients responded to immunosuppressive treatment regardless of whether MuSK antibody was present. We conclude that MuSK antibodies are present and diagnostically useful in a subset of myasthenic patients without AChR antibodies. Although the distribution of weakness differs somewhat depending on whether MuSK antibodies are present, responses to anticholinesterase and immunosuppressive treatments are similar.

Original languageEnglish (US)
Pages (from-to)55-60
Number of pages6
JournalMuscle and Nerve
Volume30
Issue number1
DOIs
StatePublished - Jul 1 2004

Fingerprint

Muscle Weakness
Protein-Tyrosine Kinases
Muscles
Antibodies
Myasthenia Gravis
Cholinergic Receptors
Immunosuppressive Agents
Serum
Neck Muscles
Cholinesterase Inhibitors
Age of Onset
Antibody Formation
Extremities

Keywords

  • Acetylcholine receptor antibody
  • Acetylcholine receptor antibody-negative myasthenic patients
  • Clinical characteristics
  • MuSK antibody
  • Myasthenia gravis

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)

Cite this

Zhou, L., McConville, J., Chaudhry, V., Adams, R. N., Skolasky, R. L., Vincent, A., & Drachman, D. B. (2004). Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients. Muscle and Nerve, 30(1), 55-60. https://doi.org/10.1002/mus.20069

Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients. / Zhou, Lan; McConville, John; Chaudhry, Vinay; Adams, Robert N.; Skolasky, Richard L.; Vincent, Angela; Drachman, Daniel B.

In: Muscle and Nerve, Vol. 30, No. 1, 01.07.2004, p. 55-60.

Research output: Contribution to journalArticle

Zhou, L, McConville, J, Chaudhry, V, Adams, RN, Skolasky, RL, Vincent, A & Drachman, DB 2004, 'Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients', Muscle and Nerve, vol. 30, no. 1, pp. 55-60. https://doi.org/10.1002/mus.20069
Zhou, Lan ; McConville, John ; Chaudhry, Vinay ; Adams, Robert N. ; Skolasky, Richard L. ; Vincent, Angela ; Drachman, Daniel B. / Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients. In: Muscle and Nerve. 2004 ; Vol. 30, No. 1. pp. 55-60.
@article{5c568e8ebd2b44f69ab2d4eb1cc4cc63,
title = "Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients",
abstract = "We assayed cryopreserved sera from 38 acetylcholine receptor (AChR) antibody-negative patients with myasthenia gravis (MG) who were followed clinically for muscle-specific tyrosine kinase (MuSK) antibodies and analyzed and compared their clinical characteristics. None of 13 sera from patients with purely ocular MG were positive. Sera from 10 of 25 patients (40{\%}) with generalized MG were positive for MuSK antibodies. The age at onset of myasthenic symptoms was significantly earlier in MuSK antibody-positive patients (P = 0.02). MuSK antibodies were present in AChR antibody-negative patients of either gender, with virtually identical prevalence in women (41.2{\%}) and men (37.5{\%}). The distribution of weakness more commonly involved neck muscles in MuSK antibody-positive patients, and limb muscles in MuSK antibody-negative patients. Patients responded to immunosuppressive treatment regardless of whether MuSK antibody was present. We conclude that MuSK antibodies are present and diagnostically useful in a subset of myasthenic patients without AChR antibodies. Although the distribution of weakness differs somewhat depending on whether MuSK antibodies are present, responses to anticholinesterase and immunosuppressive treatments are similar.",
keywords = "Acetylcholine receptor antibody, Acetylcholine receptor antibody-negative myasthenic patients, Clinical characteristics, MuSK antibody, Myasthenia gravis",
author = "Lan Zhou and John McConville and Vinay Chaudhry and Adams, {Robert N.} and Skolasky, {Richard L.} and Angela Vincent and Drachman, {Daniel B.}",
year = "2004",
month = "7",
day = "1",
doi = "10.1002/mus.20069",
language = "English (US)",
volume = "30",
pages = "55--60",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients

AU - Zhou, Lan

AU - McConville, John

AU - Chaudhry, Vinay

AU - Adams, Robert N.

AU - Skolasky, Richard L.

AU - Vincent, Angela

AU - Drachman, Daniel B.

PY - 2004/7/1

Y1 - 2004/7/1

N2 - We assayed cryopreserved sera from 38 acetylcholine receptor (AChR) antibody-negative patients with myasthenia gravis (MG) who were followed clinically for muscle-specific tyrosine kinase (MuSK) antibodies and analyzed and compared their clinical characteristics. None of 13 sera from patients with purely ocular MG were positive. Sera from 10 of 25 patients (40%) with generalized MG were positive for MuSK antibodies. The age at onset of myasthenic symptoms was significantly earlier in MuSK antibody-positive patients (P = 0.02). MuSK antibodies were present in AChR antibody-negative patients of either gender, with virtually identical prevalence in women (41.2%) and men (37.5%). The distribution of weakness more commonly involved neck muscles in MuSK antibody-positive patients, and limb muscles in MuSK antibody-negative patients. Patients responded to immunosuppressive treatment regardless of whether MuSK antibody was present. We conclude that MuSK antibodies are present and diagnostically useful in a subset of myasthenic patients without AChR antibodies. Although the distribution of weakness differs somewhat depending on whether MuSK antibodies are present, responses to anticholinesterase and immunosuppressive treatments are similar.

AB - We assayed cryopreserved sera from 38 acetylcholine receptor (AChR) antibody-negative patients with myasthenia gravis (MG) who were followed clinically for muscle-specific tyrosine kinase (MuSK) antibodies and analyzed and compared their clinical characteristics. None of 13 sera from patients with purely ocular MG were positive. Sera from 10 of 25 patients (40%) with generalized MG were positive for MuSK antibodies. The age at onset of myasthenic symptoms was significantly earlier in MuSK antibody-positive patients (P = 0.02). MuSK antibodies were present in AChR antibody-negative patients of either gender, with virtually identical prevalence in women (41.2%) and men (37.5%). The distribution of weakness more commonly involved neck muscles in MuSK antibody-positive patients, and limb muscles in MuSK antibody-negative patients. Patients responded to immunosuppressive treatment regardless of whether MuSK antibody was present. We conclude that MuSK antibodies are present and diagnostically useful in a subset of myasthenic patients without AChR antibodies. Although the distribution of weakness differs somewhat depending on whether MuSK antibodies are present, responses to anticholinesterase and immunosuppressive treatments are similar.

KW - Acetylcholine receptor antibody

KW - Acetylcholine receptor antibody-negative myasthenic patients

KW - Clinical characteristics

KW - MuSK antibody

KW - Myasthenia gravis

UR - http://www.scopus.com/inward/record.url?scp=3042852639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042852639&partnerID=8YFLogxK

U2 - 10.1002/mus.20069

DO - 10.1002/mus.20069

M3 - Article

C2 - 15221879

AN - SCOPUS:3042852639

VL - 30

SP - 55

EP - 60

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 1

ER -